🇺🇸 FDA
Patent

US 8203005

Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren

granted A61PA61P9/12

Quick answer

US patent 8203005 (Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren) held by Carbo Design LLC expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Carbo Design LLC
Grant date
Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P9/12